This protocol is our cell based method for the cholesterol termination of cholesterol reflux in ceramal plasma. Particularly in screenings. This may be applied to diagnose cardiovascular risk, and to identify or evaluate cholesterol lower maintenance.
This technique avoids the risk and burdens as the safety to with handling radiated materials by providing results with comparable quality levels, to the ones of Cholesterol reflux has been reported to associate with Thus, the plasma or ceramal cholesterol reflux of accepted can be compared, to our reference control and may provide the risk to suffer from This method will also be applied to the cell lines, like other human cell lines or even primary macro phases. Macro phases or and human induced spray button stem cells. To begin this procedure, dissolve the NPD cholesterol in pure ethanol to obtain a stock solution with a final concentration of two micromolar.
Dilute 25 microliters of the NBD cholesterol stock in AR 10 medium to reach a final concentration of five micromolar. Culture thp-1 cells in our 10 medium at 37 degrees celsius with 5%carbon dioxide. Every three days adjust the cell density to 300000 cells per milliliter.
Then obtain a 96-well plate with a flat clear bottom. For better homogenization, prepare a 10 milliliters of thp-1 cells in a 15 milliliter tube, and add 200 microliters of PMA stock. Mix gently and seed 100 microliters of the mixture into the plate wells at 200, 000 cells per well.
And incubate at 37 degrees celsius with 5%carbon dioxide for 48 to 72 hours to differentiate the thp-1 cells into DM thp-1 cells. First dilute glycine in 10%PBS with sterile water, to a concentration of 200 micromolar at pH 7.4. Add 40 milliliters of diluted glycine to 10 grams of peg 8000 to prepare a 20%peg solution, and mix vigorously to homogenize.
Next apply four parts of 20%per 10 parts of sample to each serum or plasma sample in a 1.5 ml tube. Leave the mixture on ice for 25 minutes. Centrifuge the peg apolipoprotein B precipitated at 13000 times G, and at four degrees celsius for 15 minutes.
Discard the precipitate, and transfer the supernatant to a new tube. Retrieve the plate containing the differentiated thp-1 cells. Remove and discard the culture medium, and then wash the cells twice with 1X PBS.
Add 100 microliters of 5 micromolar MVD cholesterol in AR-10 medium to each well. Incubate overnight at 37 degrees celsius with 5%carbon dioxide. The next day discard, discard the medium.
Wash the cells twice with PBS, and then add 100 microliters ABDS, or purified lipid acceptor diluted in rpmi 1630 medium to the desired concentration to each well. Include a negative control which do not contain cholesterol acceptors in a positive control, as outlined in the text protocol, and incubate at 37 degrees celsius for four to six hours. Meanwhile, prepare a 200 milliliter stock of cell lysis solution one as outlined in the text.
Mix this solution with ethanol, at a one-to-one volumetric ratio to obtain lysis solution too. For media and BD cholesterol detection, remove the cell medium from the plates in collected in a new white 96-well plate with an opaque flat bottom. Add 100 microliters of pure ethanol to 100 microliters of each medium sample to obtain a one-to-one ratio in the new plate.
Using a illuminometer, measure the fluorescent's intensity at an excitation of 463 nanometers, and an emission of 536 nanometers. For intracellular NBD cholesterol detection, wash the cells twice with PBS. Add 100 microliters of lysis solution too to each well, and incubate at room temperature, while shaking for 25 minutes.
After this, measure the fluorescent's intensity while adjusting the sensitivity parameter to 50 in the software. Then determine the cholesterol efflux rate in the final measure of cholesterol efflux as outlined in the text protocol. Diluting NBD cholesterol in pure ethanol produces the highest fluorescent's intensity values while a high content in aqueous solution, lowers the intensity.
This suggests that the fluorescent's emission of this molecule is highly dependent on the medium, in which it is contained. When using a mixture of media and ethanol at a one-to-one ratio, the fluorescent's intensity is seem to increase proportionally, with a concentration of the cholesterol analog, suggesting that the probe is behaving appropriate under these conditions. To determine the amount of time required to incubate the loaded cells with cholesterol acceptors, cell media is harvested at different time points.
The cholesterol efflux evolved linearly from zero to six hours, with the maximum signal being captured six hours after ABDS is added to the cells. The saturation threshold and dynamic range is tested by measuring the cholesterol efflux at different percentages of HDL containing media. In the high throughput asset, the efflux evolves linearly from one to 7%ABDS, reaching the peak of cholesterol efflux capacity at 7%At concentrations higher than 7%the fluroescent's intensity decreases in an inverse relationship with the ABDS percentage.
The performance of the fluorescence based method is then evaluated by comparing it to the standard radio labeled technique. Both techniques are highly correlated when using different concentrations of ABDS. The described method is sensitive to an increase of acceptor concentrations within cholesterol efflux values between five and 15%It is important to ensure that the celluarizer contains no aggregates.
Critical point is to grade an aggregate ethanol containing environment, to measure the fluorescence in a homogenous, and optimal weight. Following this procedure, name technical cholesterol can be measured, and the effect of drugs in the cholesterol efflux pathway can be determined. Also the school eventually be used as a diagnostic to asses cardiovascular risk.
We believe that this method is much easier and safer than the radioactive standard method. However it is still cell dependent. Please remember that ethanol is inflammable and it should be stored and handled accordingly.
